10 Causes of Erythema Nodosum and What They May Reveal

Erythema nodosum is a skin condition that causes tender, red or purplish lumps, most often on the front of the lower legs. These painful bumps may look like bruises as they fade, but they are usually caused by inflammation in the fatty layer beneath the skin. What makes erythema nodosum important is that it can sometimes be a reaction to something else happening in the body, such as an infection, medication reaction, inflammatory disease, or pregnancy.

Learning the possible causes of erythema nodosum can help people understand why a skin change may need more than surface-level treatment. In some cases, the condition appears after strep throat, tuberculosis, inflammatory bowel disease, sarcoidosis, certain medicines, or other immune-related triggers. Sometimes no clear cause is found, but doctors may still check for underlying conditions based on symptoms and medical history. This article explores 10 causes of erythema nodosum and what they may reveal about a person’s overall health.

What is Erythema Nodosum and What Are Its Key Symptoms?

Erythema Nodosum is a form of panniculitis, which is an inflammatory disorder affecting the subcutaneous fat, clinically presenting as tender, erythematous (red) nodules most commonly found on the shins. This condition is a delayed-type hypersensitivity reaction, serving as a cutaneous marker for a wide variety of underlying systemic diseases, infections, or drug exposures rather than being a standalone disease. Understanding its presentation is the first step toward uncovering the root cause. Below, we delve into the defining characteristics of this condition and its associated symptoms.

1. Defining the Inflammatory Skin Pathology

Erythema nodosum is defined as a reactive, inflammatory skin disorder characterized by the sudden onset of highly tender, red nodules, typically located on the shins. It is the most common form of panniculitis—an umbrella medical term for a group of conditions that cause inflammation within the subcutaneous fat layer beneath the skin.

Unlike superficial rashes that originate in the upper epidermis or dermis, this condition is rooted deep within the fibrous septa that separate fat lobules. Because the disease process occurs so deep within the tissue, these lesions are felt as firm, deep lumps rather than surface-level skin changes.

This condition is an immune-mediated hypersensitivity reaction. The body’s immune system identifies a specific target—such as a bacterial component, a drug molecule, or a self-antigen from an autoimmune condition—and triggers a localized inflammatory response. This reaction leads to inflammation of the small blood vessels within the fatty septa of the skin, resulting in painful, red nodules.

To help identify this presentation, clinicians often consult erythema nodosum pictures to evaluate the shape and symmetric distribution of the lesions during a physical exam.

                  [Deep Tissue Hypersensitivity Profile]
                                    │
       ┌────────────────────────────┴────────────────────────────┐
       ▼                                                         ▼
[Epidermal / Dermal Rashes]                             [Erythema Nodosum]
- Superficial surface scaling                           - Deep septal panniculitis
- Flat or raised plaques                                - Located in subcutaneous fat
- Confined to top skin layers                           - Firm, deep, nodular architecture

2. Investigating the Underlying Causes

This condition is rarely a standalone disease. Instead, it serves as a valuable clinical warning sign that points toward a wide range of underlying triggers. Investigating erythema nodosum causes is essential for identifying the true systemic illness driving the immune response.

                      [Primary ETIOLOGICAL TRIGGERS]
                                    │
       ┌────────────────────────────┼────────────────────────────┐
       ▼                            ▼                            ▼
[Infectious Agents]        [Systemic Illnesses]        [Pharmacological Inputs]
- Streptococcal pharyngitis - Sarcoidosis (Löfgren's)   - Oral contraceptive pills
- Tuberculosis exposure     - Inflammatory Bowel (IBD)  - Sulfonamide antibiotics
- Fungal/Deep lung spores  - Behçet's disease profile  - Bromides & Iodides

Infectious Triggers

The most common cause in children and young adults is a recent bacterial infection. Streptococcal pharyngitis (strep throat) is a primary trigger, with skin nodules typically appearing two to three weeks after the throat infection resolves. Other notable infectious causes include tuberculosis, Yersinia enteritis, and deep fungal infections such as coccidioidomycosis or histoplasmosis.

Systemic and Autoimmune Conditions

The condition can also indicate a hidden systemic inflammatory or autoimmune disease:

• Sarcoidosis: A strong link exists between these nodules and sarcoidosis. When the nodules appear alongside a fever, joint pain, and swollen lymph nodes in the chest (hilar adenopathy), it forms a specific clinical presentation known as Löfgren’s syndrome.

• Inflammatory Bowel Disease (IBD): The condition can serve as an external sign of Crohn’s disease or ulcerative colitis. The skin flares often mirror the active inflammation occurring within the patient’s digestive tract.

Medication and Hormonal Triggers

Certain prescription medications can trigger this hypersensitivity reaction. The most frequent drug-related causes include oral contraceptive pills, sulfonamide-containing antibiotics, and bromides.

Additionally, hormonal changes—such as those occurring during pregnancy—can trigger an episode due to altered immune reactivity. When no clear cause can be identified despite extensive medical testing, the condition is classified as idiopathic.

3. Cutaneous and Systemic Symptoms

The symptoms of this condition are divided into localized skin changes and widespread systemic manifestations. Systemic symptoms often develop one to three weeks before the skin nodules appear, serving as an early warning sign of the oncoming condition.

Cutaneous Symptoms and Lesion Progression

The defining feature of the condition is the sudden appearance of highly tender skin nodules. They begin as bright red, warm, firm, and painful lumps, typically measuring 1 to 5 centimeters in diameter.

The lesions are most commonly found on the shins (the front surface of the lower legs), often appearing on both legs symmetrically. Over the course of three to six weeks, the nodules change color in a predictable pattern that mimics a healing bruise—shifting from bright red to deep purple, then to a yellowish-brown, before fading away completely.

A key diagnostic feature is that these nodules resolve completely without breaking open, ulcerating, or leaving behind permanent scars. Comparing real-life cases to archived erythema nodosum pictures can help clinicians distinguish these non-scarring nodules from more destructive forms of panniculitis.

Systemic Manifestations

Because this condition is driven by systemic inflammation, the skin changes are accompanied by widespread bodily symptoms:

• Fever and Malaise: Patients routinely experience a low-grade fever, persistent fatigue, and a general feeling of being unwell, which can closely mimic the onset of a severe viral illness.

• Arthralgia and Joint Swelling: Joint pain affects more than 50% of patients. The ankles are the most frequently targeted joints, followed by the knees and wrists. This discomfort can range from mild joint aching (arthralgia) to visible swelling, redness, and heat (arthritis). In some cases, this severe joint pain can persist for several months after the skin nodules have completely cleared.

• Secondary Constitutional Signs: Depending on the underlying cause, patients may also experience a persistent cough (often linked to sarcoidosis or lung infections), severe headaches, or abdominal cramping and chronic diarrhea (associated with underlying inflammatory bowel disease).

10 Common Triggers for Erythema Nodosum and the Diseases They Signal

The 10 common triggers for Erythema Nodosum include infections (Streptococcus, Tuberculosis, Yersiniosis, Coccidioidomycosis), systemic inflammatory diseases (Sarcoidosis, IBD, Behçet’s Disease), medications, pregnancy, and idiopathic cases where no cause is found. Each of these triggers sets off a hypersensitivity reaction that manifests as inflammation in the subcutaneous fat, signaling a distinct underlying medical condition that requires investigation and management. Identifying the specific cause is paramount, as the treatment and prognosis are directly linked to the underlying disease.

1. Pathogenic Triggers: Bacterial and Fungal Sources

Erythema nodosum serves as a vital clinical warning sign, frequently triggered by an underlying infectious process. When the body encounters certain bacterial or fungal pathogens, the immune system can launch a delayed-type hypersensitivity reaction. This response causes deep, painful inflammation within the fatty layers of the skin, making it essential to identify the underlying erythema nodosum causes to properly guide patient care.

                  [Infectious Hypersensitivity Inflow]
                                    │
       ┌────────────────────────────┴────────────────────────────┐
       ▼                                                         ▼
[Bacterial Antigens]                                    [Fungal Antigens]
- Group A Streptococcus (Pharyngitis)                   - Coccidioides immitis (Spore Inhalation)
- Mycobacterium tuberculosis (Primary Tuberculid)        - Triggers localized "Desert Rheumatism"
- Yersinia enterocolitica (Undercooked Pork/Water)       - Indicates robust, protective immunity

1. Streptococcal Infections

Post-streptococcal reactions represent the most common identifiable cause of this skin condition, particularly in children and young adults. The nodules typically appear two to three weeks after an episode of Group A streptococcal pharyngitis (strep throat).

As the immune system fights the bacteria, it forms circulating immune complexes that deposit in the small blood vessels of the subcutaneous fat. Clinicians confirm this trigger using a rapid strep test, a throat culture, or by detecting elevated Antistreptolysin O (ASO) titers in a blood sample.

2. Tuberculosis (TB)

The sudden appearance of these tender nodules can be a key external sign of a primary infection with Mycobacterium tuberculosis. In this scenario, the skin lesions are considered a reactive phenomenon known as a tuberculid, signaling that the body is mounting a powerful cell-mediated immune defense against the bacteria.

In areas where TB is common, diagnosing this condition requires an immediate medical workup, including a chest X-ray and an Interferon-Gamma Release Assay (IGRA) or PPD skin test.

3. Yersiniosis

This trigger stems from a gastrointestinal infection caused by Yersinia enterocolitica, typically contracted by consuming contaminated water or undercooked pork. The bacteria cause acute gastroenteritis, marked by a fever, severe abdominal pain, and diarrhea.

The characteristic red skin nodules usually develop one to two weeks after the digestive symptoms begin. This specific link is most frequently diagnosed in European countries through stool cultures or targeted antibody testing.

4. Coccidioidomycosis (Valley Fever)

This fungal infection is caused by inhaling Coccidioides spores, which are native to the dry soil of the southwestern United States and parts of Central and South America. The infection typically starts in the lungs as a mild, flu-like illness.

When the skin nodules appear alongside a fever and severe joint pain, the presentation is clinically known as “desert rheumatism.” The development of these nodules is actually a positive sign, indicating that the patient’s immune system has mounted a strong defense capable of containing the fungus and preventing it from spreading throughout the body.

2. Systemic Inflammatory and Autoimmune Indicators

When this condition is not triggered by an infection, it is often driven by an internal, dysregulated immune response. The development of these tender skin nodules can be an early sign of a systemic autoimmune or autoinflammatory disease.

5. Sarcoidosis (Löfgren’s Syndrome)

Sarcoidosis is a systemic disease characterized by the growth of tiny collections of inflammatory cells, known as non-caseating granulomas, within various organs—most commonly the lungs and lymph nodes. This skin condition is one of its most frequent external signs.

When these painful nodules appear together with a high fever, severe joint pain (particularly in the ankles), and swollen lymph nodes in the chest cavity on an X-ray, it forms a specific clinical triad called Löfgren’s syndrome. This acute presentation generally points to a good prognosis, as this specific form of sarcoidosis often resolves on its own without needing long-term immunosuppressive therapy.

6. Inflammatory Bowel Disease (IBD)

These painful skin lumps are the most common skin manifestation associated with Inflammatory Bowel Disease, occurring in up to 15% of patients with Crohn’s disease and 10% of those with ulcerative colitis.

The appearance of these lesions is directly tied to the activity of the underlying intestinal disease; a sudden flare-up of skin nodules often signals a matching flare-up of inflammation within the digestive tract. Consequently, when a patient presents with these nodules alongside abdominal cramping, chronic diarrhea, or rectal bleeding, a prompt evaluation for IBD is necessary.

[Active Crohn's / UC Flare] ──► Intestinal Wall Inflammation ──► Systemic Vascular Hypersensitivity ──► Skin Nodules

7. Behçet’s Disease

Behçet’s disease is a rare, chronic inflammatory disorder characterized by widespread inflammation of the blood vessels (vasculitis) throughout the body. The classic diagnostic signs include recurrent, painful mouth sores, genital ulcers, and severe eye inflammation (uveitis).

The skin nodules that develop in Behçet’s disease can look identical to classic cases on the surface, but when examined under a microscope, they often reveal true destruction of the blood vessel walls (vasculitis). Recognizing these lesions alongside recurrent oral or genital ulcers is a crucial step in diagnosing this systemic condition.

3. Pharmacological, Physiological, and Idiopathic Triggers

In many cases, the condition is not caused by an underlying disease or infection, but rather develops as a reaction to a medication, a hormonal shift, or without any identifiable trigger.

8. Medications

A wide variety of prescription drugs can cause this hypersensitivity reaction, with skin lesions typically appearing within one to three weeks after starting the medication:

• Oral Contraceptive Pills: Estrogen-containing birth control pills are one of the most common drug triggers. The synthetic hormones are thought to alter immune system reactivity, and the nodules typically resolve once the medication is stopped.

• Sulfonamides: This class of antibiotics is a well-known cause of drug-induced skin reactions, including this nodular condition.

• Other Implicated Agents: Additional medications linked to this reaction are frequently found in certain cough syrups or medical imaging contrast dyes and specialized cancer therapies like BRAF inhibitors.

9. Pregnancy

This condition can develop during pregnancy, most frequently during the second trimester. It is thought to be triggered by the significant rise in natural hormone levels, particularly estrogen, which alters the body’s baseline immune responses.

While these nodules can be quite painful and distressing for the expectant mother, the condition does not harm the developing fetus and typically resolves on its own within a few weeks after delivery.

10. Idiopathic Manifestations

Despite a thorough medical investigation, 30% to 60% of all cases are classified as idiopathic, meaning no underlying infection, systemic disease, or medication trigger can be found.

This is a diagnosis of exclusion, made only after a physician has ruled out all other potential causes. While it can be frustrating not to find a specific source, the prognosis for idiopathic cases is excellent. The condition resolves on its own and is managed supportively with bed rest, leg elevation, and nonsteroidal anti-inflammatory drugs (NSAIDs) to control localized pain and swelling.

The Process for Diagnosing and Managing Erythema Nodosum

The diagnosis and management of Erythema Nodosum involve a two-pronged approach that first confirms the condition through clinical examination and selective testing, and then focuses on identifying and treating the underlying trigger while providing symptomatic relief for the painful skin nodules. Furthermore, this process requires careful differentiation from similar-looking skin conditions to ensure appropriate care and to accurately assess the patient’s long-term outlook, which is generally positive but can involve recurrence if the root cause is not addressed.

1. The Clinical Diagnostic Framework

Confirming a diagnosis of erythema nodosum requires a two-step medical approach where clinicians first visually identify the skin lesions and then perform a targeted diagnostic workup to uncover the underlying systemic trigger driving the inflammatory response. The diagnostic process begins with a physical examination focused on the unique anatomical preference of the condition. It typically presents as painful, firm, red nodules located symmetrically across the anterior surfaces of both shins.

During palpation, the physician evaluates the depth of the nodules, confirming that the inflammation sits deep within the subcutaneous fat layer rather than on the surface of the skin. A thorough patient history is taken at the bedside, specifically screening for recent respiratory infections, new medication exposures, or unexpected gastrointestinal changes that could point toward an internal cause.

To confirm a clinical diagnosis and isolate the primary trigger, a standardized panel of diagnostic tests must be ordered. Serological inflammatory markers are assessed through a complete blood count to check for active infection, alongside Erythrocyte Sedimentation Rate and C-Reactive Protein assays to measure system-wide inflammation.

An Antistreptolysin O titer is also included to check for a recent, unrecognized streptococcal infection. If the patient reports a recent sore throat, a direct microbial throat culture is performed to check for Group A beta-hemolytic streptococci. Furthermore, a chest X-ray is a fundamental component of the diagnostic workup to screen for bilateral hilar lymphadenopathy, which points to sarcoidosis, or active pulmonary infiltrates indicative of tuberculosis.

If the clinical presentation remains unusual, a deep incisional skin biopsy extending down into the fat layer is performed. Under a microscope, the tissue characteristically reveals septal panniculitis without vasculitis, meaning the immune cells are clustered exclusively within the fibrous connective walls separating the fat lobules without destroying the nearby blood vessels.

                  [Diagnostic Diagnostic Investigative Flow]
                                      │
     ┌────────────────────────┬───────┴────────┬────────────────────────┐
     ▼                        ▼                ▼                        ▼
[Serological Assays]   [Microbiology]   [Chest Radiography]      [Deep Tissue Biopsy]
- CBC Evaluation       - Throat Swab    - Rules out Sarcoidosis  - Confirms Septal
- Elevated ESR & CRP   - Tracks Strep     (Hilar Adenopathy)       Panniculitis
- High ASO Titers        Pharyngitis    - Screens for Active TB  - Rules out Vasculitis

2. Differential Diagnostics: Distinguishing Look-Alike Lesions

Because many inflammatory conditions present with painful, red swelling on the lower legs, clinicians must carefully distinguish this condition from look-alike illnesses before starting a treatment plan. Cellulitis is a deep bacterial infection of the dermis and subcutaneous tissues, most commonly caused by Streptococcus or Staphylococcus species.

While it looks similar on the surface, cellulitis is almost always unilateral and confined to a single leg, spreads rapidly across the skin, and features poorly defined borders. Unlike the firm, deep nodules of a panniculitis reaction, cellulitis causes an area of flat, expanding skin warmth and swelling, and is frequently accompanied by a high fever, chills, and an obvious break in the skin that allowed the bacteria to enter.

The distinction from other forms of fat inflammation, such as erythema induratum of Bazin, is more nuanced but equally important. Erythema induratum is a distinct type of fat inflammation that is centered within the fat lobules themselves and involves the direct inflammation of blood vessels, possessing a strong historical link to an underlying tuberculosis infection. While erythema nodosum is a septal panniculitis that presents symmetrically on the anterior shins and resolves without ulceration or scarring, erythema induratum presents as chronic, purplish nodules typically located on the posterior calves.

These lobular lesions frequently break down and ulcerate, leading to permanent, deep scars upon healing. Other rare forms, like alpha-1 antitrypsin deficiency panniculitis, also present with tender nodules but are characterized by extensive ulceration and an oily discharge that requires a deep skin biopsy to definitively distinguish based on histopathological features.

3. Comprehensive Treatment and Management Strategies

The primary treatment goal is to identify and resolve the underlying cause. If a medication is identified as one of the primary erythema nodosum causes, it must be discontinued immediately; if a bacterial infection is found, targeted antibiotics are prescribed. While the underlying trigger is being addressed, secondary management focuses on reducing local pain and tissue inflammation.

Mechanical interventions are the first line of non-pharmacological care. Patients are advised to practice strict bed rest and elevate their legs above heart level, which lowers hydrostatic pressure in the lower extremities, reduces swelling, and eases tissue tension. Once the initial painful phase subsides, wearing graduated compression stockings can help support the veins and manage long-term leg swelling.

                    [Symptomatic Management Protocol]
                                    │
       ┌────────────────────────────┼────────────────────────────┐
       ▼                            ▼                            ▼
[Mechanical Rest]          [First-Line Medications]    [Advanced Interventions]
- Strict bed rest          - High-dose NSAIDs          - Potassium Iodide drops
- Elevate legs above heart   (Ibuprofen / Naproxen)    - Systemic Corticosteroids
- Reduces edema/pressure   - Inhibits prostaglandins     (Only after ruling out TB)

Pharmacological protocols rely heavily on nonsteroidal anti-inflammatory drugs, such as ibuprofen, naproxen, or indomethacin, which serve as the initial treatment choice. These medications block prostaglandin synthesis, providing rapid relief from joint pain and nodule tenderness. For persistent or recurring cases, a temporary course of oral potassium iodide solution can be highly effective because the compound helps stabilize cell membranes and suppress the release of inflammatory oxygen radicals from white blood cells.

In severe, non-infectious cases that do not respond to first-line therapies, a brief course of oral prednisone may be used to quickly reduce inflammation. However, doctors must definitively rule out underlying infections like tuberculosis or deep systemic fungi before starting steroids, as suppressing the immune system could cause these infections to spread dangerously. To aid in monitoring therapy, clinicians often reference baseline erythema nodosum pictures to visually track the reduction in nodule diameter and redness over time.

4. Prognosis and Recurrence Pathways

The long-term outlook for individuals with this condition is generally excellent. Because it is a self-limiting process, the painful nodules typically resolve on their own within three to six weeks, even without intensive medical intervention. As the lesions heal, they undergo a characteristic color change that looks like a fading bruise—shifting from bright red to deep purple, and finally to a faint yellowish-brown.

A reassuring aspect of this condition is that the nodules resolve without breaking open or leaving behind permanent scars. While some patients may notice temporary darkening of the skin due to post-inflammatory hyperpigmentation, this skin tone change naturally fades away over the following months.

[Persistent or Re-Exposed Trigger] ──► Immune System Reactivation ──► Nodule Recurrence on Shins

However, a patient’s long-term outlook is ultimately determined by the underlying cause. If the trigger is a chronic systemic disease, like Crohn’s disease or sarcoidosis, new crops of nodules will often appear to mirror active flare-ups of the underlying illness. Similarly, if the initial reaction was caused by a specific medication, such as an oral contraceptive pill or a sulfonamide antibiotic, re-exposing the patient to that drug will often trigger a recurrence. Idiopathic cases have a low rate of recurrence, but identifying and avoiding known triggers remains the most effective way to prevent future episodes.

Conclusion

Erythema nodosum is often more than a simple rash because it may reflect the body’s reaction to infection, inflammation, medication, or another medical condition. Common causes include strep infections, tuberculosis, sarcoidosis, inflammatory bowel disease, pregnancy, certain drugs, and other immune or infectious triggers. In many cases, the bumps improve once the underlying cause is treated or controlled. If painful nodules appear on the legs, especially with fever, joint pain, cough, digestive symptoms, or recent medication changes, medical evaluation can help identify what may be behind them.

Read more: 7 Signs of Atypical Depression That Are Easy to Misread

Frequently Asked Questions

1. What is erythema nodosum?

Erythema nodosum is an inflammatory skin condition that affects the fat layer under the skin. It usually causes tender, red, swollen bumps on the shins, though other areas can be involved. The bumps may turn purple or bruise-like as they heal. It is often a reaction to another trigger rather than a skin infection itself.

2. What causes erythema nodosum?

Erythema nodosum can be caused by infections, medications, pregnancy, autoimmune conditions, inflammatory bowel disease, and other inflammatory disorders. Strep throat is one of the common infectious triggers. Conditions such as sarcoidosis, tuberculosis, Crohn’s disease, and ulcerative colitis may also be linked. In some cases, no specific cause is found even after evaluation.

3. Can erythema nodosum reveal an infection?

Yes, erythema nodosum may sometimes reveal an infection that needs attention. Streptococcal infection is a well-known cause, especially after a sore throat. Tuberculosis, certain fungal infections, and other bacterial infections may also be considered depending on location, symptoms, and risk factors. A doctor may order tests if fever, cough, sore throat, or other warning signs are present.

4. Is erythema nodosum linked to inflammatory bowel disease?

Yes, erythema nodosum can be linked to inflammatory bowel disease, including Crohn’s disease and ulcerative colitis. It may appear during a digestive flare or occur alongside abdominal pain, diarrhea, weight loss, or blood in the stool. The skin bumps may improve when the bowel inflammation is treated. This connection is one reason persistent or unexplained erythema nodosum should be medically reviewed.

5. How is erythema nodosum treated?

Treatment for erythema nodosum depends on the cause and the severity of symptoms. Mild cases may improve with rest, leg elevation, cold compresses, and pain relief recommended by a healthcare provider. If an infection, medication reaction, or inflammatory disease is responsible, treating that trigger is important. People should avoid stopping prescribed medicines without speaking with a doctor first.

Sources

• Erythema Nodosum: Symptoms, Causes & Treatment (Cleveland Clinic)
• Erythema Nodosum: Symptoms, Causes, and Management (DermNet)
• Erythema Nodosum (Johns Hopkins Medicine)
• Erythema Nodosum (Cedars-Sinai)
• Erythema Nodosum – StatPearls (NCBI Bookshelf)
• Erythema Nodosum: A Practical Approach and Diagnostic Algorithm (PMC)
• Erythema Nodosum (PubMed)